Preclinical studies suggest many ways that ALCAR may benefit the brain
Such knowledge will help us achieve a deep understanding of OAs complicated pathological processes, provide new insight for developing novel therapeutics targeting this debilitating disease, improve clinical outcome, and patient well-being
Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission
The behavioral tests were conducted to assess the cognitive, motor, and emotional impacts of MSG, and the effectiveness of Vit D and N-3 PUFA treatment
J Chem Inf Model 54(7):19511962 LeDuc JW, Barry MA (2004) SARS, the first pandemic of the 21st century
A systematic review of retinoic acid in the journey of spermatogonium to spermatozoa: From basic to clinical application